|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
5 months to Dec 31, 2020
|
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares | |||
| General and administrative expenses paid by Sponsor under note payable | |||
| Reduction in the carrying amount of ROU assets | |||
| Depreciation and amortization | |||
| Stock-based compensation | |||
| Compensation expense related to secondary sale | |||
| Amortization of debt issuance costs | |||
| Non-cash interest expense | |||
| Accretion expense | |||
| Expenses related to invoices in dispute | |||
| Loss on disposal of research and development equipment | |||
| Other | |||
| Revaluation of warrant liability to estimated fair value | |||
| Loss on disposal of property and equipment and inventory | |||
| Changes in operating assets and liabilities: | |||
| Prepaid expenses | |||
| Accrued expenses | |||
| Accounts receivable | |||
| Inventory | |||
| Prepaid expenses and other current assets | |||
| Prepaid partnership costs | |||
| Operating lease right-of-use asset | |||
| Other non-current assets | |||
| Accounts payable | |||
| Due to related party | |||
| Accrued expenses and other current liabilities | |||
| Accrued interest | |||
| Deferred revenue | |||
| Lease incentive liability | |||
| Operating lease liability | |||
| Other noncurrent liabilities | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities | |||
| Cash deposited in Trust Account | |||
| Purchase of property and equipment | |||
| Capitalization of internal-use software | |||
| Lease incentives received | |||
| Cash paid for acquisition of 2Predict | |||
| Acquisition of OpConnect patent | |||
| Net cash used in investing activities | |||
| Cash flows from financing activities | |||
| Due from employees for taxes paid on partial recourse notes | |||
| Proceeds received from initial public offering, gross | |||
| Offering costs paid | |||
| Proceeds from issuance of Series D Preferred Stock | |||
| Payments of long term debt | |||
| Payment of short-term debt | |||
| Payment of long-term debt | |||
| EIP Loan reimbursement | |||
| Payment of PPP Loan | |||
| Proceeds from exercise of stock options | |||
| Payment of debt issuance costs | |||
| Proceeds from financing activity | |||
| Payment of issuance costs related to Series D and D-1 Preferred Stock | |||
| Proceeds from issuance of common stock upon equity offering, net of fees | |||
| Payment of financing activity principal | |||
| Proceeds from Reverse Recapitalization and PIPE Financing | |||
| Proceeds from exercise of common stock warrants - related party | |||
| Taxes paid related to net share settlement of equity awards | |||
| Proceeds from refunds of transaction costs related to Reverse Recapitalization | |||
| Payment of transaction costs related to Reverse Recapitalization | |||
| Net cash (used in) provided by financing activities | |||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||
| Net increase in cash and cash equivalents | |||
| Cash and cash equivalents, beginning of period | |||
| Cash and cash equivalents, end of period | |||
| Supplemental disclosures of cash flow information | |||
| Offering costs included in accrued expenses | |||
| Offering costs included in note payable | |||
| Deferred underwriting commissions | |||
| Deferred legal fees | |||
| Initial value of Class A ordinary shares subject to possible redemption | |||
| Change in value of Class A ordinary shares subject to possible redemption | |||
| Cash paid for interest | |||
| Cash paid for taxes | |||
| Non-cash investing and financing activities | |||
| Purchases of property and equipment not yet settled | |||
| Conversion of redeemable convertible Preferred Stock into common stock in connection with the Reverse Recapitalization | |||
| Initial recognition of operating lease right-of-use asset | |||
| Initial recognition of operating lease liability | |||
| Change in warrant classification from liability to equity | |||
| ROU assets obtained in exchange for operating lease liabilities | |||
| Class B common stock warrants issued in satisfaction of services rendered | |||
| Forfeiture of shares to settle promissory notes collateralized to common stock | |||
| Cashless exercise of Legacy Volta Preferred Stock Warrants | |||
| Issuance of Series D-1 Preferred Stock in satisfaction of debt and other liabilities | |||
| Secondary sales of common stock pledged against partial recourse notes - related party | |||
| Common stock issued for acquisition of 2Predict | |||
| Issuance of common stock for patent acquisition | |||
| Stock-based compensation capitalized to internal-use software |
Loading...